Sensorion Logo

Sensorion

Clinical-stage biotech developing novel therapies for inner ear disorders and hearing loss.

ALSEN | PA

Overview

Corporate Details

ISIN(s):
FR0012596468 (+2 more)
LEI:
969500P0W8XJ9CGZDP97
Country:
France
Address:
375 RUE DU PROFESSEUR BLAYAC, 34080 MONTPELLIER

Description

Sensorion is a clinical-stage biotechnology company specializing in the development of novel therapies for inner ear disorders. The company's mission is to address the significant unmet medical need of hearing loss by creating innovative therapeutic solutions. Its strategy is built on three pillars: restoring hearing through gene therapies for genetic diseases, treating existing hearing disorders with small molecule therapeutics, and preventing non-genetic hearing loss, such as drug-induced ototoxicity. Sensorion utilizes a unique R&D technology platform to advance its understanding of the pathophysiology of inner ear diseases and develop its pipeline of clinical candidates.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-19 07:30
Inside Information / Other news releases
English 172.3 KB
2025-12-19 07:30
Informations privilégiées / Autres communiqués
French 174.6 KB
2025-12-08 07:30
Inside Information / Other news releases
English 216.7 KB
2025-12-08 07:30
Informations privilégiées / Autres communiqués
French 234.1 KB
2025-09-17 07:30
Inside Information / News release on accounts, results
English 253.3 KB
2025-09-17 07:30
Informations privilégiées / Communiqué sur comptes, résultats
French 273.6 KB
2025-09-04 07:30
Inside Information / Other news releases
English 168.5 KB
2025-09-04 07:30
Informations privilégiées / Autres communiqués
French 174.1 KB
2025-08-15 07:30
Inside Information / Other news releases
English 139.2 KB
2025-08-15 07:30
Informations privilégiées / Autres communiqués
French 140.2 KB
2025-07-31 09:17
Inside Information / Other news releases
English 193.1 KB
2025-07-31 09:17
Informations privilégiées / Autres communiqués
French 186.2 KB
2025-07-29 07:30
Inside Information / Other news releases
English 188.2 KB
2025-07-29 07:30
Informations privilégiées / Autres communiqués
French 192.0 KB
2025-07-01 07:30
Inside Information / Other news releases
English 187.9 KB

Automate Your Workflow. Get a real-time feed of all Sensorion filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sensorion

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sensorion via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-04-11 N/A Other Other 2,781,914 1,752,605.82 EUR
2024-04-11 N/A Other Other 1,587,301 999,999.63 EUR
2024-02-13 N/A Other Other 16,842,105 9,599,999.85 EUR
2024-02-08 N/A Other Other 12,280,701 6,999,999.57 EUR
2023-08-08 N/A Other Other 46,428,571 12,999,999.88 EUR
2023-08-03 N/A Other Other 25,000,000 7,000,000.00 EUR

Peer Companies

Vor Biopharma Inc. Logo
A clinical-stage biotech developing therapies that target the source of autoimmunity.
United States of America
VOR
WDB coco CO.,LTD. Logo
A CRO providing support services to the pharmaceutical and medical device sectors.
Japan
7079
Whitehawk Therapeutics, Inc. Logo
A preclinical oncology company developing advanced antibody-drug conjugate therapies.
United States of America
WHWK
WOOJUNG BIO, Inc. Logo
Offers pre-clinical CRO services, research facility engineering, and startup incubation.
South Korea
215380
XEROS TECHNOLOGY GROUP PLC Logo
Develops and licenses polymer-based solutions that reduce industrial water consumption.
United Kingdom
XSG
Xilio Therapeutics, Inc. Logo
A clinical-stage biotech developing tumor-activated immuno-oncology therapies for cancer.
United States of America
XLO
Xintela AB Logo
Biomedical company developing stem cell therapies for regenerative medicine and oncology.
Sweden
XINT
Xlife Sciences AG Logo
Develops and commercializes early-stage life sciences research projects.
Switzerland
XLS
Y-Biologics, Inc Logo
Develops antibody-based therapeutics for cancer, focusing on immuno-oncology.
South Korea
338840
YD Bio Ltd Logo
Develops blood-based cancer diagnostics and regenerative cell therapies.
United States of America
YDES

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.